|
Synonyms: ABBV-101 | Compound 1 [US20240109877]
Compound class:
Synthetic organic
Comment: Omtebrutideg is the INN for a Bruton tyrosine kinase PROTAC degrader. It is proposed for antineoplastic effects. The structure indicates that it is designed to engage the cereblon (CRBN) E3 ubiquitin ligase. Available evidence suggests that omtebrutideg is likely the INN for Abbvie's lead BTK PROTAC ABBV-101 [2-3]. Targeted protein degradation is intended as a strategy to overcome BTK inhibitor resistance in B cell malignancies.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Ligand families/groups | PROTACs, molecular glues and other degraders |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13940 | omtebrutideg |
Synonyms ![]() |
| ABBV-101 | Compound 1 [US20240109877] |
Database Links ![]() |
|
| CAS Registry No. | 2988804-46-0 (source: WHO INN record) |
| GtoPdb PubChem SID | 530846873 |
| PubChem CID | 169081326 |
| Search Google for chemical match using the InChIKey | IFISVDOJTJUTBK-WUFINQPMSA-N |
| Search Google for chemicals with the same backbone | IFISVDOJTJUTBK |
| Search PubMed clinical trials | omtebrutideg |
| Search PubMed titles | omtebrutideg |
| Search PubMed titles/abstracts | omtebrutideg |
| UniChem Compound Search for chemical match using the InChIKey | IFISVDOJTJUTBK-WUFINQPMSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | IFISVDOJTJUTBK-WUFINQPMSA-N |